Publications

Mayer, Bryan T., Lily Zhang, Allan C. deCamp-, -Michel Nussenzweig, Kathryn E. Stephenson, Boris Julg-, and -Huub C. Gelderblom. 2024. “Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People Without HIV”. Pharmaceutics 16.

Julg, Boris, Kathryn E. Stephenson, Frank Tomaka, Stephen R. Walsh, Sabrina Tan, Ludo Lavreys-, -Hanneke Schuitemaker, and Dan H. Barouch. 2024. “Immunogenicity of 2 Therapeutic Mosaic HIV-1 Vaccine Strategies in Individuals With HIV-1 on Antiretroviral Therapy”. NPJ Vaccines 9.

Dussupt, Vincent, Rajeshwer S. Sankhala, Gregory D. Gromowski-, -Kathryn E. Stephenson-, Gordon Joyce, and Shelly J. Krebs. 2020. “Potent Zika and Dengue Cross-Neutralizing Antibodies Induced by Zika Vaccination in a Dengue-Experienced Donor”. Nature Medicine 26 (2): 228-35.

Stephenson, Kathryn E., Frank Wegmann, Frank Tomaka-, -Hanneke Schuitemaker, and Dan H. Barouch. 2020. “Comparison of Shortened Mosaic HIV-1 Vaccine Schedules: A Randomised, Double-Blind, Placebo-Controlled Phase 1 Trial (IPCAVD010/HPX1002) and a Preclinical Study in Rhesus Monkeys (NHP 17-22)”. Lancet HIV 7 (6): e410-e421.

Stephenson, Kathryn E., Kshitij Wagh, Bette Korber, and Dan H. Barouch. 2020. “Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention”. Annual Reviews Immunology 98: 673-703.

Stephenson, Kathryn E., Chen Sabrina Tan, Stephen R. Walsh-, -Kayvon Modjarrad, and Dan H. Barouch. 2020. “Safety and Immunogenicity of a Zika Purified Inactivated Virus Vaccine Given via Standard, Accelerated, or Shortened Schedules: A Single-Centre, Double-Blind, Sequential-Group, Randomised, Placebo-Controlled, Phase 1 Trial”. Lancet Infectious Diseases 20 (9): 1061-70.